The Canadian Institutes of Health Research (CIHR), the CIHR Institute of Infection and Immunity, Institute of Aging, Institute of Genetics, Institute of Gender and Health, Institute of Health Services and Policy Research, Institute of Human Development, Child and Youth Health, Institute of Musculoskeletal Health and Arthritis, the CIHR Centre for Research on Pandemic Preparedness and Health Emergencies, the CIHR HIV/AIDS and Sexually Transmitted and Blood-borne Infections Research Initiative, in partnership with the Alzheimer Society of Canada, the Azrieli Foundation, BrightFocus Foundation and Fighting Blindness Canada.
For More Information
Additional information,can be found at the CIHR website
The CIHR REDI Early Career Transition Award is available to post-doctoral researchers, clinicians, and research associates from specific underrepresented groups to help them launch their research faculty careers in Canada. The first launch is open to racialized women and Black people. Future launches of the REDI award will support additional populations and will continue to promote the growth of diverse research communities.
See the Message from the CIHR President and Scientific Director of the CIHR Institute of Infection and Immunity introducing this award.This preannouncement contains information on the funding opportunity for potential applicants.
Anticipated Timelines (subject to change)
- Program Launch: December 2022
- Webinar #1 with Q&A:
- 19 December from 1-2:30 pm ET (English)
- 20 December from 1-2:30 pm ET (French)
- Webinar #2 with Q&A:
- 1 February from 12-1:30 pm ET (English)
- 2 February from 12-1:30 pm ET (French)
- Application Deadline: May 2023
- Notice of Decision: September 2023
- Funding Start Date: 1 July 2023
For an application to be eligible:
- The Nominated Principal Applicant (NPA) must:
- self identify with at least one of the following groups: racialized women or Black people; and
- be a trainee by the Funding Start Date at a CIHR eligible academic institution, health system or research institution and, specifically, one of the following: a PhD-holding post-doctoral researcher; a clinician holding an MD, DVM, DDS or a PhD or equivalent doctoral degree-holding allied health professional in either a post-doctoral position, or a faculty position denoting independence in clinical responsibilities but not in research; or a research associate or equivalent who is a PhD-holding researcher.
The Primary Mentor must be an independent researcher with an academic appointment and be either the NPA's current supervisor or a principal investigator who will function as the NPA's Primary Mentor for their Phase 1 REDI project. Additional mentors do not need to hold an academic appointment.
Note: In relation to these criteria, eligibility will be determined using the response(s) provided in the Equity, Diversity and Inclusion Self-identification Questionnaire. The Equity, Diversity, and Inclusion Self-Identification Questionnaire will be updated in December and therefore will be unavailable at launch. Once updated, applicants will be required to complete the questionnaire by the application deadline, in addition to all the other application requirements, in order to be considered for this funding opportunity.
Refer to the funding opportunity for the complete set of eligibility criteria.
The total amount available for the 2022 funding opportunity for Phase 1 and 2 is $25,080,000 enough to fund approximately thirty-eight (38) awards.
Maximum Project Value
- The mentored Phase 1 (2-3 years) includes a $20,000/year research allowance, a $70,000/year stipend, mentorship, and career development. Applicants will propose a Research Project for Phase 1 that will establish the foundation for their independent research program as faculty members in Phase 2. Applicants must work with their Primary Mentor to identify how they will distinguish their proposed research project from their Primary Mentor's research program.
- The independent Phase 2 (3-4 years) includes at least $240,000/year in research allowance and salary support, and faculty mentorship. Awardees are expected to transition to an independent research faculty position – marking the start of Phase 2 – within 2 to 3 years of the funding start date.
(This includes minimum 1:1 matching of CIHR funds by the Phase 2 host institution.)